Skip to content

OncoDNA

Active Public limited companyfounded 2012active for 13 yearsRue Louis Breguet 1, 6041 CharleroiKBO/BCE: BE 0501.631.837

Board

5 directors, 1 auditor, no change since June 2026
Director
appointed by deed of 16-06-2023 3-year term from 2026
also on the board of 3 other companies
Director
appointed by deed of 16-06-2023 3-year term from 2026
Director
appointed by deed of 16-06-2023 3-year term from 2026
also on the board of 4 other companies
Director, permanent representative Guy Geldhof
appointed by deed of 16-06-2023 3-year term from 2026
Director, permanent representative François Fontaine
appointed by deed of 16-06-2023 3-year term from 2026
also on the board of 43 other companies
2 other companies bankrupt
Statutory auditor, permanent representative Julie Delforge
current term since 02-06-2025 3-year term from 2026
listed in the 2025 annual accounts, filed on 14-07-2026
Member of the executive committee
appointed by deed of 28-07-2022
Member of the executive committee
appointed by deed of 28-07-2022
Financial director, permanent representative Virginie De Coster
appointed by deed of 20-06-2024
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Two directors jointly
deed of 04-06-2026
Permanent representatives 3
François Fontaine
appointed by deed of 16-06-2023
Guy Geldhof
Permanent representative, for GELDHOF ENTERPRISES
appointed by deed of 16-06-2023
Virginie De Coster
Permanent representative, for FINADEC
appointed by deed of 20-06-2024

Office holders in the KBO →

Mandates through the years

34 names, the dashed line is today
Show
An Herremans
Director
François Degrave
Member of the executive committee
Koenraad Eycken
Member of the executive committee
FINADEC
Financial director
Bernard Courtieu
Director general
Alain Declercq
Director (not named in the articles)
Innosté
Director
Swisscanto (CH) Private Equity Switzerland Growth I KmGK
Director (not named in the articles)
Synneo SRL
Member of the executive committee
BIO.BE
Director
INVENTURES
Director
Ignis Consulting SARL
Daily management delegate
Grégori Ghitti
It director
Jean-François Laes
Member of the executive committee
Michelle Meijer
Sales director
Pierre Flamant
Member of the executive committee
Ignis Counsulting SARL
Member of the executive committee
AMNASSEN
Director
SPARAXIS
Director
BoardOther functionEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
  • SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
    • Director, appointed by deed of 12-03-2019, still in office
  • François BLONDEL
    • Director (not named in the articles), from 25-11-2019 to 16-06-2023
    • Director, appointed by deed of 16-06-2023, still in office
  • GELDHOF ENTERPRISES
    • Director (not named in the articles), appointed by deed of 20-12-2019, until 16-06-2023
    • Director, appointed by deed of 16-06-2023, still in office
  • An Herremans
    • Director, from 02-07-2021 to date
  • Charles-André Brouwers
    • Independent director, from 02-07-2021 to 16-06-2023
    • Director, appointed by deed of 16-06-2023, still in office
  • Deloitte Réviseurs d'Entreprises
    • Statutory auditor, appointed by deed of 01-12-2016, still in office
  • François Degrave
    • Member of the executive committee, appointed by deed of 28-07-2022, still in office
  • Koenraad Eycken
    • Member of the executive committee, appointed by deed of 28-07-2022, still in office
  • FINADEC
    • Financial director, appointed by deed of 20-06-2024, still in office
  • William E. Rhodes, III
    • Director, until 20-08-2024
  • Bernard Courtieu
    • Director general, appointed by deed of 15-07-2021, until 20-06-2024
  • Alain Declercq
    • Director (not named in the articles), from 23-12-2020 to 16-06-2023
  • Innosté
    • Chair of the board, appointed by deed of 10-11-2020, ended, last mentioned on 10-11-2020
    • Director, appointed by deed of 10-11-2020, until 16-06-2023
  • Jean-Pol DETIFFE
    • Director, appointed by deed of 14-12-2012, until 16-06-2023
    • Daily management delegate, appointed by deed of 14-12-2012, until 01-09-2016
    • Director general, appointed by deed of 04-07-2018, ended, last mentioned on 04-07-2018
  • Swisscanto (CH) Private Equity Switzerland Growth I KmGK
    • Director (not named in the articles), from 07-02-2020 to 16-06-2023
  • William R. "Bill" Rhodes
    • Independent director, from 02-07-2021 to 16-06-2023
    • Director, appointed by deed of 16-06-2023, no longer listed in the 2025 annual accounts
  • Synneo SRL
    • Member of the executive committee, until 26-08-2021
  • BIO.BE
    • Director, appointed by deed of 14-12-2012, until 09-08-2021
  • INVENTURES
    • Director, appointed by deed of 09-03-2017, until 09-08-2021
  • John-Eric BERTRAND
    • Director, appointed by deed of 16-09-2016, until 09-08-2021
  • Jean STEPHENNE
    • Director, appointed by deed of 14-12-2012, until 01-10-2020
    • Chair of the board, appointed by deed of 23-09-2016, ended, last mentioned on 23-09-2016
    • Director, until 18-01-2021
  • Sambrinvest spin-off/spin-out
    • Director, appointed by deed of 14-12-2012, until 18-01-2021
  • Ignis Consulting SARL
    • Daily management delegate, appointed by deed of 23-09-2016, until 01-08-2020
  • Grégori Ghitti
    • It director, appointed by deed of 04-07-2018, no longer listed in the 2025 annual accounts
  • Jean-François Laes
    • Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2018
  • Michelle Meijer
    • Sales director, appointed by deed of 04-07-2018, no longer listed in the 2025 annual accounts
  • Pierre Flamant
    • Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2018
  • Ignis Counsulting SARL
    • Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2017
  • AMNASSEN
    • Chair of the board, appointed by deed of 14-12-2012, until 01-09-2016
    • Chair of the board, appointed by deed of 14-12-2012, last mentioned in 2012
    • Director, appointed by deed of 14-12-2012, last mentioned in 2016
  • SPARAXIS
    • Director, appointed by deed of 16-09-2016, no longer listed in the 2025 annual accounts
  • Jean-Michel Verhaegen
    • Director, appointed by deed of 14-12-2012, no longer listed in the 2025 annual accounts
  • Philippus JANSSENS de VAREBEKE
    • Director, from before 14-06-2016, no longer listed in the 2025 annual accounts
  • Pierre LEFESVRE
    • Director, appointed by deed of 14-12-2012, until 31-03-2014
  • Philippe JANSSENS de VAREBEKE
    • Director, appointed by deed of 14-12-2012, no longer listed in the 2025 annual accounts

Control

Shareholder
Equity €11.45bn
Profit €290.9m in 2025 (profit €315.2m in 2024)
17.46%
This company
OncoDNA
Equity -€256,642
Loss €3.8m in 2025

and 6 other shareholders

Capital

Capital
€2,672,435.77
Shares
23,870,625 in the deed of 04-06-2026
Source
deed of 04-06-2026

Owners through the years

as the annual accounts name them

Source: lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 04-06-2026 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Conseil d'administration, minimum trois (3) administrateurs”
“Trois ans au plus, Ils sont rééligibles”
“Le conseil d'administration peut, sous sa propre responsabilité, désigner des mandataires avec le titre et les pouvoirs qu'il détermine”
deed of 04-06-2026 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Thursday of June
deed of 04-06-2026 (in French)
Auditor ruleThe articles set how a statutory auditor is appointed and what they check.
“Trois ans au plus, commissaires”
deed of 26-06-2023 (in French)
Dissolution ruleThe articles set when and by whom the company can be dissolved.
“Dont elle fixe les pouvoirs et les émoluments, à moins que l'assemblée générale des actionnaires ne nomme des liquidateurs”
deed of 18-04-2025 (in French)

Shareholders

7 owners

Capital transactions

Shareholders according to the deeds
Share transfer deed of 18-04-2025 ↗
  • shares transferred 214,713 shares
  • shares transferred 214,713 shares
After 11 capital increases deed of 26-06-2023 ↗
Stated in the deed deed of 26-06-2023 ↗
Stated in the deed deed of 09-08-2021 ↗
After 3 capital increases deed of 18-01-2021 ↗
Stated in the deed deed of 18-01-2021 ↗
Show 8 older mentions
After 2 capital increases deed of 14-04-2020 ↗
  • Verve Investment Syndicates GmbH 132,001 shares · €825,006.25 in cash
  • Future Capital AG 80,000 shares · €500,000 in cash
  • David Wicki-Birchler 80,000 shares · €500,000 in cash
  • Société Fédérale de Participation et d'Investissement 320,000 shares · €2,000,000 in cash
Stated in the deed deed of 14-04-2020 ↗
After the capital increase deed of 05-03-2020 ↗
Stated in the deed deed of 20-12-2019 ↗
After 2 capital increases deed of 12-03-2019 ↗
After 3 capital increases deed of 09-03-2017 ↗
  • BUSINESS INNOVATION S.L. 8,361 shares
  • Adriana TERRADEZ LAVERGNE 1,150 shares
  • Pierre FLAMANT 10,869 shares
After the capital increase deed of 18-01-2016 ↗
  • Jean-Pol DETIFFE 1,953 shares
  • Michaël HERMAN 254 shares
  • Gregori GHITTI 254 shares
  • Jean-Francois LAES 469 shares
  • Invest4OncoDNA 29,297 shares
  • SCDC VINSOVIER 19,531 shares
  • Jean-Marie HENROTIN 4,883 shares
  • BIO.BE 39,062 shares
  • SAMBRINVEST SPIN-OFF/SPIN-OUT 29,297 shares
At incorporation deed of 14-12-2012 ↗
Capital over time
  1. 04-06-2026 Capital increase of €1,068,083.76 · to €2,672,435.77 · 1,235,636 new shares at €0.86 per share · in cash
  2. 04-06-2026 Capital reduction of €2,500,000 · to €172,435.77 · to absorb losses
  3. 04-06-2026 Capital increase of €9 · to €172,444.77 · 171,000 new shares, 0.7% of the 23,870,625 shares after the increase · “exercice de droits de souscription anti-dilutifs”
  4. 18-04-2025 Capital reduction of €13,683,878.26 · to €1,104,337.01 · to absorb losses
  5. 18-04-2025 Capital increase of €500,000 · to €1,604,337.01 · 3,731,365 new shares · in kind
  6. 18-04-2025 Capital increase of €15 · to €1,604,352.01 · 6,053,627 new shares, 26.9% of the 22,463,989 shares after the increase · in cash
  7. 18-04-2025 Capital reduction of €13,683,878.26 · to €1,104,337.01 · to absorb losses
  8. 18-04-2025 Capital increase of €500,000 · to €1,604,337.01 · 3,731,365 new shares · in kind
Show 30 older capital entries
  1. 18-04-2025 Converted to unavailable equity · €2,723,749
  2. 18-04-2025 Capital increase of €15 · to €1,604,352.01 · 6,053,627 new shares, 26.9% of the 22,463,989 shares after the increase · in cash
  3. 26-06-2023 Capital reduction of €22,330,494.74 · to €8,128,884.71 · to absorb losses
  4. 26-06-2023 Capital increase of €6,659,305.56 · to €14,788,190.27 · 1,640,202 new shares · in kind
  5. 26-06-2023 Capital increase of €131,354.17 · 32,353 new shares · in kind
  6. 26-06-2023 Capital increase of €226,812.50 · 55,864 new shares · in kind
  7. 26-06-2023 Capital increase of €99,512.83 · 24,509 new shares · in kind
  8. 26-06-2023 Capital increase of €30,241.67 · 7,448 new shares · in kind
  9. 26-06-2023 Capital increase of €52,541.67 · 12,941 new shares · in kind
  10. 26-06-2023 Capital increase of €20,161.11 · 4,965 new shares · in kind
  11. 26-06-2023 Capital increase of €187,830.77 · 46,262 new shares · in kind
  12. 26-06-2023 Capital increase of €268,074.70 · 66,028 new shares · in kind
  13. 26-06-2023 Capital increase of €6,659,305.56 · to €14,788,190.27 · 1,640,202 new shares · in kind
  14. 26-06-2023 Capital increase of €25 · to €14,788,215.27 · “conversion des Warrants Anti-Dilutifs”
  15. 09-08-2021 Capital increase of €500,000 · 80,000 new shares at €6.25 per share · in cash
  16. 18-01-2021 Capital increase of €8,488,910 · to €29,665,379.45 · 1,358,222 new shares at €6.25 per share · in kind
  17. 18-01-2021 Capital increase of €294,000 · to €29,959,379.45 · 47,040 new shares · in cash
  18. 14-04-2020 Capital increase of €3,825,006.25 · 612,001 new shares · in cash
  19. 05-03-2020 Capital increase of €7,129,350 · to €17,351,463.20 · 1,140,696 new shares, 18.4% of the 6,199,896 shares after the increase
  20. 20-12-2019 Capital increase of €4,000,000 · 640,000 new shares
  21. 12-07-2019 Capital stated in the deed · €6,222,113.20
  22. 12-03-2019 Capital increase of €2,605,583.20 · to €6,222,113.20 · 398,670 new shares · in kind
  23. 12-03-2019 Capital increase of €2,525,000 · 404,000 new shares · in cash
  24. 01-06-2018 Capital reduction of €7,696,851.58 · to €1,205,397.92 · to absorb losses
  25. 09-03-2017 Capital increase of €43,750.60 · to €8,852,252.10 · 9,511 new shares · in kind
  26. 09-03-2017 Capital increase of €49,997.40 · to €8,902,249.50 · 10,869 new shares, 0.3% of the 3,616,530 shares after the increase · in cash
  27. 16-09-2016 Capital increase of €168,500.50 · to €1,308,500.50 · 240,715 new shares at €0.70 per share
  28. 16-09-2016 Capital increase of €7,500,001 · to €8,808,501.50 · 1,630,435 new shares at €4.60 per share, 45.3% of the 3,596,150 shares after the increase
  29. 18-01-2016 Capital increase of €500,000 · to €1,140,000 · 125,000 new shares
  30. 14-12-2012 Incorporation · €640,000 · 6,400 shares

The directors' other companies

1 current director with another company that went bankrupt, was dissolved or struck off

2 other companies of this director went bankrupt (2019, 2025).

Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.

Next steps